Channelpedia

Kv11.1

2538 literature references associated to Kv11.1

used / unused
Pubmed id

1

364826

5

365116

Su Z et al. Novel cell-free high-throughput screening method for pharmacological tools targeting K+ channels.
Proc. Natl. Acad. Sci. U.S.A., 2016 May 17 , 113 (5748-53).

9

364694

Colatsky T et al. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress.
J Pharmacol Toxicol Methods, 2016 Jun 6 , ().

10

365194

Carbonell-Pascual B et al. Comparison between Hodgkin-Huxley and Markov formulations of cardiac ion channels.
J. Theor. Biol., 2016 Jun 21 , 399 (92-102).

13

364743

Yamaguchi Y et al. Latent pathogenicity of the G38S polymorphism of KCNE1 K(+) channel modulator.
Heart Vessels, 2016 Jun 2 , ().

16

364733

Wu W et al. Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.
Card Electrophysiol Clin, 2016 Jun , 8 (275-84).

22

361354

24

361241

Gintant G et al. Evolution of strategies to improve preclinical cardiac safety testing.
Nat Rev Drug Discov, 2016 Feb 19 , ().

28

365584

31

365146

Liu F et al. Cotranslational association of mRNA encoding subunits of heteromeric ion channels.
Proc. Natl. Acad. Sci. U.S.A., 2016 Apr 26 , 113 (4859-64).

35

365612

36

361408

Ichikawa M et al. Multigenerational Inheritance of Long QT Syndrome Type 2 in a Japanese Family.
Intern. Med., 2016 , 55 (259-62).

38

356722

Hassinen M et al. Molecular basis and drug sensitivity of the delayed rectifier (IKr) in the fish heart.
Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2015 Oct-Nov , 176-177 (44-51).

39

356797

Arcangeli A et al. Novel perspectives in cancer therapy: Targeting ion channels.
Drug Resist. Updat., 2015 Jul-Aug , 21-22 (11-9).

40

367837

42

362387

González Cabrera D et al. Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
J. Med. Chem., 2015 Sep 24 , 58 (7572-9).

50

366169

Lees-Miller JP et al. In response to Melgari et al. "hERG potassium channel inhibition by ivabradine requires channel gating".
J. Mol. Cell. Cardiol., 2015 Oct , 87 (192-3).

51

366208

Melgari D et al. hERG potassium channel inhibition by ivabradine requires channel gating.
J. Mol. Cell. Cardiol., 2015 Oct , 87 (126-8).

52

357342

Frea S et al. New echocardiographic insights in short QT syndrome: More than a channelopathy?
Heart Rhythm, 2015 Oct , 12 (2096-105).

53

365901

Lee HJ et al. Mechanism of inhibition by olanzapine of cloned hERG potassium channels.
Neurosci. Lett., 2015 Nov 16 , 609 (97-102).

56

368232

Zhao H et al. Discovery of novel N-aryl piperazine CXCR4 antagonists.
Bioorg. Med. Chem. Lett., 2015 Nov 1 , 25 (4950-5).

57

368233

Delaunois A et al. Cardiac safety of lacosamide: the non-clinical perspective.
Acta Neurol. Scand., 2015 Nov , 132 (337-45).

62

357738

Leren IS et al. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
JACC Cardiovasc Imaging, 2015 May , 8 (501-10).

64

348613

65

358184

66

355366

Perry MD et al. Getting to the heart of hERG K(+) channel gating.
J. Physiol. (Lond.), 2015 Mar 27 , ().

67

355367

68

367434

Goodchild SJ et al. Sequence of gating charge movement and pore gating in HERG activation and deactivation pathways.
Biophys. J., 2015 Mar 24 , 108 (1435-47).

69

367435

70

367436

71

348493

Biliczki P et al. The interaction between delayed rectifier channel alpha-subunits does not involve hetero-tetramer formation.
Naunyn Schmiedebergs Arch. Pharmacol., 2015 Mar 20 , ().

72

358075

73

348537

75

359312

Yang L et al. Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
Anesthesiology, 2015 Mar , 122 (571-84).

76

356645

Han SN et al. [Effects of midazolam on hERG K+ channel].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2015 Mar , 31 (143-7).

77

356913

82

357816

Wu W et al. The Link between Inactivation and High-Affinity Block of hERG1 Channels.
Mol. Pharmacol., 2015 Jun , 87 (1042-50).

84

364041

Zhao X et al. Up-regulation of miR-21 and miR-23a Contributes to As2 O3 -induced hERG Channel Deficiency.
Basic Clin. Pharmacol. Toxicol., 2015 Jun , 116 (516-23).

87

356691

Stattin EL et al. Genetic screening in sudden cardiac death in the young can save future lives.
Int. J. Legal Med., 2015 Jul 31 , ().

88

356707

Zhang W et al. Kcnh2 and Kcnj8 Interactively Regulate Skin Wound Healing and Regeneration.
Wound Repair Regen, 2015 Jul 28 , ().

89

362794

Yue Y et al. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
Circulation, 2015 Jul 28 , 132 (230-40).

91

356790

Lee S et al. Cellular mechanisms for trazodone-induced cardiotoxicity.
Hum Exp Toxicol, 2015 Jul 17 , ().

93

357437

95

366724

Issa NP et al. QT interval prolongation in a patient with LQT2 on levetiracetam.
Seizure, 2015 Jul , 29 (134-6).

99

348969

100

349039

Wiśniowska B et al. Enhanced QSAR models for drug-triggered inhibition of the main cardiac ion currents.
J Appl Toxicol, 2015 Jan 5 , ().

102

350133

Vedani A et al. OpenVirtualToxLab--a platform for generating and exchanging in silico toxicity data.
Toxicol. Lett., 2015 Jan 22 , 232 (519-32).

103

348893

Saber S et al. Complex genetic background in a large family with Brugada syndrome.
Physiol Rep, 2015 Jan 1 , 3 ().

104

358978

Lynch SM et al. N-Aryl azacycles as novel sodium channel blockers.
Bioorg. Med. Chem. Lett., 2015 Jan 1 , 25 (48-52).

105

360806

Riuró H et al. Genetic analysis, in silico prediction, and family segregation in long QT syndrome.
Eur. J. Hum. Genet., 2015 Jan , 23 (79-85).

108

349322

110

363870

Chae YJ et al. Effects of donepezil on hERG potassium channels.
Brain Res., 2015 Feb 9 , 1597 (77-85).

113

348729

Männikkö R et al. Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23.
Br. J. Pharmacol., 2015 Feb 12 , ().

116

348817

Vijayvergiya V et al. Single channel and ensemble hERG conductance measured in droplet bilayers.
Biomed Microdevices, 2015 Feb , 17 (12).

117

349491

124

361639

126

361749

127

362069

Sviripa VM et al. Par-4 secretion: stoichiometry of 3-arylquinoline binding to vimentin.
Org. Biomol. Chem., 2015 Dec 15 , 14 (74-84).

128

356537

Sundby E et al. In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib.
Eur J Pharm Sci, 2015 Dec 1 , 80 (56-65).

131

368091

Liang D et al. [Expression of human ether-a-go-go-related gene in laryngeal carcinoma].
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2015 Dec , 29 (2160-3).

132

367031

134

362625

Chen J et al. Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel.
J. Biol. Chem., 2015 Aug 21 , 290 (21101-13).

139

356610

140

356609

141

366810

142

367187

Osterbur ML et al. An Interdomain KCNH2 Mutation Produces an Intermediate Long QT Syndrome.
Hum. Mutat., 2015 Aug , 36 (764-73).

145

367292

Zhang C et al. Identification of Low-Risk Adult Congenital LQTS Patients.
J. Cardiovasc. Electrophysiol., 2015 Aug , 26 (853-8).

146

362724

148

356577

Zhang J et al. [Effects of allitridum on rapidly delayed rectifier potassium current in HEK293 cell line].
Nan Fang Yi Ke Da Xue Xue Bao, 2015 Aug , 35 (1128-32, 1142).

150

363469

Chae YJ et al. Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels.
Eur. J. Pharmacol., 2015 Apr 5 , 752 (1-7).

153

363096

Ferreiro SF et al. Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTX.
Toxins (Basel), 2015 Apr , 7 (1030-47).

154

367205

155

364097

161

356933

166

357016

Pugsley MK et al. Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist.
Handb Exp Pharmacol, 2015 , 229 (149-203).

168

366937

Martelli A et al. Inhibitors of the renal outer medullary potassium channel: a patent review.
Expert Opin Ther Pat, 2015 , 25 (1035-51).

169

366294

Shi YQ et al. Mechanisms underlying probucol-induced hERG-channel deficiency.
Drug Des Devel Ther, 2015 , 9 (3695-704).

173

366166

Shi YQ et al. High Glucose Represses hERG K+ Channel Expression through Trafficking Inhibition.
Cell. Physiol. Biochem., 2015 , 37 (284-96).

174

366101

Lastraioli E et al. hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers.
Biomed Res Int, 2015 , 2015 (896432).

175

363305

Giacomini E et al. A ligand-based virtual screening approach to identify small molecules as HERG channel activators.
Comb. Chem. High Throughput Screen., 2015 , 18 (269-80).

179

362900

Jing Y et al. In silico prediction of hERG inhibition.
Future Med Chem, 2015 , 7 (571-86).

181

348696

182

348622

183

349137

186

350232

Gibson JK et al. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
J Pharmacol Toxicol Methods, 2014 Nov-Dec , 70 (255-67).

187

350741

Mirams GR et al. Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
J Pharmacol Toxicol Methods, 2014 Nov-Dec , 70 (246-54).

188

353366

189

354195

191

350414

192

359865

Brudeli B et al. Discovery and pharmacological profile of new hydrophilic 5-HT(4) receptor antagonists.
Bioorg. Med. Chem. Lett., 2014 Sep 15 , 24 (4598-602).

193

350785

197

344657

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

198

359953

Kim Y et al. Novel thienopyrimidinones as mGluR1 antagonists.
Eur J Med Chem, 2014 Oct 6 , 85 (629-37).

199

349752

Kauthale RR et al. Assessment of temperature-induced hERG channel blockade variation by drugs.
J Appl Toxicol, 2014 Oct 28 , ().

200

359870

Kratz JM et al. Experimentally validated HERG pharmacophore models as cardiotoxicity prediction tools.
J Chem Inf Model, 2014 Oct 27 , 54 (2887-901).

202

359568

Perlmutter JI et al. Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.
J. Med. Chem., 2014 Oct 23 , 57 (8540-62).

203

359644

204

360248

Nogawa H et al. hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia.
Eur. J. Pharmacol., 2014 Oct 15 , 741 (336-9).

205

350391

Olde Nordkamp LR et al. Syncope in genotype-negative long QT syndrome family members.
Am. J. Cardiol., 2014 Oct 15 , 114 (1223-8).

206

367922

Wu W et al. Cooperative subunit interactions mediate fast C-type inactivation of hERG1 K+ channels.
J. Physiol. (Lond.), 2014 Oct 15 , 592 (4465-80).

208

360955

209

350095

211

359387

Linder T et al. Structural insights into trapping and dissociation of small molecules in K⁺ channels.
J Chem Inf Model, 2014 Nov 24 , 54 (3218-28).

212

349500

Colenso CK et al. Voltage sensor gating charge transfer in a hERG potassium channel model.
Biophys. J., 2014 Nov 18 , 107 (L25-8).

214

349976

217

359340

221

364317

Zhao X et al. The rescuable function and mechanism of resveratrol on As₂O₃-induced hERG K⁺ channel deficiency.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Nov , 387 (1079-89).

223

345349

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

228

353412

Wang Q et al. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
J. Cardiovasc. Electrophysiol., 2014 May , 25 (522-30).

229

345489

Hill AP et al. Kinetics of drug interaction with the Kv11.1 potassium channel.
Mol. Pharmacol., 2014 May , 85 (769-76).

233

353179

234

355305

Koenig X et al. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.
Addict Biol, 2014 Mar , 19 (237-9).

235

352926

Rodríguez-Ravelo R et al. A K⁺ channel blocking peptide from the Cuban scorpion Rhopalurus garridoi.
Peptides, 2014 Mar , 53 (42-7).

237

352357

239

347671

Pond AL et al. The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression.
Muscle Nerve, 2014 Mar , 49 (378-88).

241

344560

242

344422

243

344461

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

247

345375

251

360088

252

360497

Sherhod R et al. Emerging pattern mining to aid toxicological knowledge discovery.
J Chem Inf Model, 2014 Jul 28 , 54 (1864-79).

254

355612

Bando S et al. Congenital long QT syndrome with compound mutations in the KCNH2 gene.
Heart Vessels, 2014 Jul , 29 (554-9).

255

352634

Glengarry JM et al. Long QT molecular autopsy in sudden infant death syndrome.
Arch. Dis. Child., 2014 Jul , 99 (635-40).

257

344169

González Cabrera D et al. 2,4-Diaminothienopyrimidines as Orally Active Antimalarial Agents.
J. Med. Chem., 2014 Jan 28 , ().

258

344135

Radresa O et al. Roles of PKC Isoforms in PMA-Induced Modulation of the hERG Channel (Kv11.1).
J Biomol Screen, 2014 Jan 24 , ().

259

341741

Gohlke BO et al. SuperPain--a resource on pain-relieving compounds targeting ion channels.
Nucleic Acids Res., 2014 Jan 1 , 42 (D1107-12).

261

341427

264

354465

265

353190

268

353370

269

346089

270

346229

Thurner P et al. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine.
J. Pharmacol. Exp. Ther., 2014 Feb , 348 (346-58).

272

354824

Ferreiro SF et al. In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats.
Arch. Toxicol., 2014 Feb , 88 (425-34).

273

354788

Zhang Y et al. The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.
Pediatr Cardiol, 2014 Feb , 35 (295-300).

274

349991

Roder K et al. RING finger protein RNF207, a novel regulator of cardiac excitation.
J. Biol. Chem., 2014 Dec 5 , 289 (33730-40).

275

358869

Jones DK et al. hERG 1b is critical for human cardiac repolarization.
Proc. Natl. Acad. Sci. U.S.A., 2014 Dec 16 , 111 (18073-7).

277

358875

Lim CJ et al. Synthesis and SAR of thieno[3,2-b]pyridinyl urea derivatives as urotensin-II receptor antagonists.
Bioorg. Med. Chem. Lett., 2014 Dec 15 , 24 (5832-5).

281

364417

Strauss KA et al. A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorder.
Hum. Mol. Genet., 2014 Dec 1 , 23 (6395-406).

282

359035

283

359417

284

358691

Lin EC et al. Mouse ERG K(+) channel clones reveal differences in protein trafficking and function.
J Am Heart Assoc, 2014 Dec , 3 (e001491).

286

359280

287

350166

Li P et al. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
J. Pharmacol. Exp. Ther., 2014 Dec , 351 (596-604).

289

351105

Schmidtke P et al. Dynamics of hERG closure allow novel insights into hERG blocking by small molecules.
J Chem Inf Model, 2014 Aug 25 , 54 (2320-33).

291

351636

293

350080

294

351539

Hajj A et al. KCNH2 polymorphism and methadone dosage interact to enhance QT duration.
Drug Alcohol Depend, 2014 Aug 1 , 141 (34-8).

295

351197

296

353539

297

355927

Liu LL et al. Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.
Acta Pharmacol. Sin., 2014 Aug , 35 (1093-102).

299

360191

Gong Q et al. Identification of Kv11.1 isoform switch as a novel pathogenic mechanism of long-QT syndrome.
Circ Cardiovasc Genet, 2014 Aug , 7 (482-90).

302

345107

Martinson AS et al. Functional evolution of Erg potassium channel gating reveals an ancient origin for IKr.
Proc. Natl. Acad. Sci. U.S.A., 2014 Apr 15 , 111 (5712-7).

303

352328

Chanséaume A et al. [KCNH2 gene new mutation in a patient with prior diagnosis of epilepsy].
Rev. Neurol. (Paris), 2014 Apr , 170 (304-5).

304

352141

Heijman J et al. Cardiac safety assays.
Curr Opin Pharmacol, 2014 Apr , 15 (16-21).

305

354191

Noriega-Navarro R et al. Novel TASK channels inhibitors derived from dihydropyrrolo[2,1-a]isoquinoline.
Neuropharmacology, 2014 Apr , 79 (28-36).

306

353740

Silvestre JS et al. Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics.
J. Psychopharmacol. (Oxford), 2014 Apr , 28 (329-40).

307

352140

Sanguinetti MC HERG1 channel agonists and cardiac arrhythmia.
Curr Opin Pharmacol, 2014 Apr , 15 (22-7).

308

352483

Wu W et al. Stoichiometry of altered hERG1 channel gating by small molecule activators.
J. Gen. Physiol., 2014 Apr , 143 (499-512).

309

345339

Wang D et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths.
Forensic Sci. Int., 2014 Apr , 237 (90-9).

310

344538

Tester DJ et al. GENETICS OF LONG QT SYNDROME.
Methodist Debakey Cardiovasc J, 2014 1 , 10 (29-33).

314

350109

Shao XD et al. The mechanism of COX-2 regulating HERG channel in gastric cancer cells.
Bratisl Lek Listy, 2014 , 115 (487-91).

319

345608

Munoz C et al. Up-regulation of Kir2.1 (KCNJ2) by the serum & glucocorticoid inducible SGK3.
Cell. Physiol. Biochem., 2014 , 33 (491-500).

321

350355

Shimizu W Clinical and genetic diagnosis for inherited cardiac arrhythmias.
J Nippon Med Sch, 2014 , 81 (203-10).

323

355992

325

350183

326

351802

Braga RC et al. Tuning HERG out: antitarget QSAR models for drug development.
Curr Top Med Chem, 2014 , 14 (1399-415).

327

352913

329

353113

Pakladok T et al. Up-regulation of hERG K⁺ channels by B-RAF.
PLoS ONE, 2014 , 9 (e87457).

333

354432

Goodchild SJ et al. Gating charge movement precedes ionic current activation in hERG channels.
Channels (Austin), 2014 , 8 (84-9).

334

350805

Liu J et al. Patch-clamp technique in ESC-derived cardiomyocytes.
Methods Mol. Biol., 2014 , 1181 (203-14).

336

354078

Sanders NG et al. Antimalarial efficacy of hydroxyethylapoquinine (SN-119) and its derivatives.
Antimicrob. Agents Chemother., 2014 , 58 (820-7).

339

359279

342

360229

344

359800

Zhang K et al. Berberine induces hERG channel deficiency through trafficking inhibition.
Cell. Physiol. Biochem., 2014 , 34 (691-702).

345

359777

Lee SH et al. Blockade of HERG human K+ channels by the antidepressant drug paroxetine.
Biol. Pharm. Bull., 2014 , 37 (1495-504).

346

360228

349

342026

Zeng H et al. Halide Ion Effects on Human Ether-à-go-go Related Gene Potassium Channel Properties.
Assay Drug Dev Technol, 2013 Nov-Dec , 11 (544-50).

351

335392

Morissette P et al. The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (137-49).

352

335375

Elkins RC et al. Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (112-22).

354

348091

Rampe D et al. A history of the role of the hERG channel in cardiac risk assessment.
J Pharmacol Toxicol Methods, 2013 Jul-Aug , 68 (13-22).

356

355620

Chun YS et al. Cholesterol regulates HERG K+ channel activation by increasing phospholipase C β1 expression.
Channels (Austin), 2013 Jul-Aug , 7 (275-87).

357

343927

358

339515

Haugaa KH et al. Abnormal electroencephalograms in patients with long QT syndrome.
Heart Rhythm, 2013 Sep 27 , ().

359

347066

Czodrowski P hERG me out.
J Chem Inf Model, 2013 Sep 23 , 53 (2240-51).

362

342324

Haitin Y et al. The structural mechanism of KCNH-channel regulation by the eag domain.
Nature, 2013 Sep 19 , 501 (444-8).

363

339578

366

339621

Cordeiro JM et al. Developmental changes in expression and biophysics of ion channels in the canine ventricle.
J. Mol. Cell. Cardiol., 2013 Sep 10 , 64C (79-89).

371

346943

372

346944

373

347947

Nawathe PA et al. An LQTS6 MiRP1 mutation suppresses pacemaker current and is associated with sinus bradycardia.
J. Cardiovasc. Electrophysiol., 2013 Sep , 24 (1021-7).

374

347143

Zhang P et al. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
J. Pharm. Pharmacol., 2013 Sep , 65 (1321-8).

375

347873

Fischer F et al. Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2013 Sep , 386 (795-804).

378

346759

Meng J et al. Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization.
Eur. J. Pharmacol., 2013 Oct 15 , 718 (87-97).

381

339946

382

339526

Andreasen L et al. Genetic Modifier of the QTc Interval Associated With Early-Onset Atrial Fibrillation.
Can J Cardiol, 2013 Oct , 29 (1234-40).

383

342218

Yoshinaga M et al. Electrocardiographic screening of 1-month-old infants for identifying prolonged QT intervals.
Circ Arrhythm Electrophysiol, 2013 Oct , 6 (932-8).

385

353400

Fiore A et al. Characterization of hERG1 channel role in mouse colorectal carcinogenesis.
Cancer Med, 2013 Oct , 2 (583-94).

386

335415

Salyer SA et al. Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells.
Biochim. Biophys. Acta, 2013 Oct , 1832 (1734-43).

387

346513

Lee YS et al. Long QT syndrome: a Korean single center study.
J. Korean Med. Sci., 2013 Oct , 28 (1454-60).

388

361099

390

354194

392

342289

Stump MR et al. LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation.
Am. J. Physiol. Heart Circ. Physiol., 2013 Nov 1 , 305 (H1397-404).

397

347763

Almilaji A et al. AMP-activated protein kinase regulates hERG potassium channel.
Pflugers Arch., 2013 Nov , 465 (1573-82).

398

335887

403

343281

Mitton-Fry MJ et al. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
Bioorg. Med. Chem. Lett., 2013 May 15 , 23 (2955-61).

404

335450

Leifert A et al. Differential hERG ion channel activity of ultrasmall gold nanoparticles.
Proc. Natl. Acad. Sci. U.S.A., 2013 May 14 , 110 (8004-9).

405

336264

de la Peña P et al. Mapping of interactions between the N- and C-termini and the channel core in HERG K+ channels.
Biochem. J., 2013 May 1 , 451 (463-74).

411

347765

Aziz PF et al. Do LQTS gene single nucleotide polymorphisms alter QTc intervals at rest and during exercise stress testing?
Ann Noninvasive Electrocardiol, 2013 May , 18 (288-93).

415

336630

416

336068

Babcock JJ et al. hERG channel function: beyond long QT.
Acta Pharmacol. Sin., 2013 Mar , 34 (329-35).

417

341326

Hashimoto R et al. The KCNH2 gene is associated with neurocognition and the risk of schizophrenia.
World J. Biol. Psychiatry, 2013 Mar , 14 (114-20).

418

341278

421

335523

Munoz C et al. Klotho sensitivity of the hERG channel.
FEBS Lett., 2013 Jun 5 , 587 (1663-8).

422

334939

Steinke K et al. Coxsackievirus B3 modulates cardiac ion channels.
FASEB J., 2013 Jun 27 , ().

425

341078

Ginman T et al. Core refinement toward permeable β-secretase (BACE-1) inhibitors with low hERG activity.
J. Med. Chem., 2013 Jun 13 , 56 (4181-205).

427

335318

Wang S et al. Recent developments in computational prediction of HERG blockage.
Curr Top Med Chem, 2013 Jun 1 , 13 (1317-26).

429

335137

Townsend C et al. Predicting Drug-Induced QT Prolongation and Torsades de Pointes: A Review of Preclinical Endpoint Measures.
Curr Protoc Pharmacol, 2013 Jun , Chapter 10 (Unit10.16).

430

336021

431

335240

432

343368

433

343568

Stowasser M Primary aldosteronism and potassium channel mutations.
Curr Opin Endocrinol Diabetes Obes, 2013 Jun , 20 (170-9).

435

342864

436

348108

Arcangeli A et al. High hERG1 expression in advanced melanoma.
Melanoma Res., 2013 Jun , 23 (185-90).

437

342663

Brelidze TI et al. Structure of the C-terminal region of an ERG channel and functional implications.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 9 , 110 (11648-53).

438

334879

Nilsson MF et al. Comparative effects of sodium channel blockers in short term rat whole embryo culture.
Toxicol. Appl. Pharmacol., 2013 Jul 8 , ().

443

342865

Ryu S et al. The synergic modeling for the binding of fluoroquinolone antibiotics to the hERG potassium channel.
Bioorg. Med. Chem. Lett., 2013 Jul 1 , 23 (3848-51).

444

335463

Takanari H et al. Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue.
Cardiovasc. Res., 2013 Jul 1 , 99 (203-14).

445

335594

447

347948

448

347738

Rayan A et al. Indexing molecules for their hERG liability.
Eur J Med Chem, 2013 Jul , 65 (304-14).

451

336873

Di Martino GP et al. An automated docking protocol for hERG channel blockers.
J Chem Inf Model, 2013 Jan 28 , 53 (159-75).

452

336893

453

337560

Di Veroli GY et al. High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jan 1 , 304 (H104-17).

455

341140

Narayana Moorthy NS et al. Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design.
Curr Drug Targets, 2013 Jan 1 , 14 (102-13).

457

337769

Zarzoso M et al. Mission possible: RNA interference rescues the hERG current.
Heart Rhythm, 2013 Jan , 10 (137-8).

461

339011

Ng CA et al. Insights into hERG K+ channel structure and function from NMR studies.
Eur. Biophys. J., 2013 Jan , 42 (71-9).

462

347860

Wei T et al. [Effect of berberine, liensinine and neferine on HERG channel expression].
Zhongguo Zhong Yao Za Zhi, 2013 Jan , 38 (239-44).

464

331270

465

330413

469

340888

Hausammann GJ et al. Generation of an antibody toolbox to characterize hERG.
Biochem. Biophys. Res. Commun., 2013 Feb 1 , 431 (70-5).

470

340805

Harris RA et al. Human metastable epiallele candidates link to common disorders.
Epigenetics, 2013 Feb , 8 (157-63).

471

343802

Yang LJ et al. New targets for the antitumor activity of gambogic acid in hematologic malignancies.
Acta Pharmacol. Sin., 2013 Feb , 34 (191-8).

472

336610

Gustina AS et al. The eag domain regulates hERG channel inactivation gating via a direct interaction.
J. Gen. Physiol., 2013 Feb , 141 (229-41).

473

337393

Dong H et al. Functional expression of ERG1 potassium channels in rat alveolar macrophages.
J. Mol. Histol., 2013 Feb , 44 (117-24).

474

337390

475

336510

Silva D et al. Novel mutation in the KCNH2 gene associated with long QT syndrome.
Rev Port Cardiol, 2013 Feb , 32 (163-4).

477

346197

Hausammann GJ et al. Chimeric hERG channels containing a tetramerization domain are functional and stable.
Biochemistry, 2013 Dec 23 , 52 (9237-45).

478

341521

Shi YP et al. External protons destabilize the activated voltage sensor in hERG channels.
Eur. Biophys. J., 2013 Dec 21 , ().

480

346366

485

354449

Goineau S et al. In vitro safety cardiovascular pharmacology studies: impact of formulation preparation and analysis.
Regul. Toxicol. Pharmacol., 2013 Dec , 67 (499-505).

486

360987

Lin J et al. [Protein tyrosine phosphatase non-receptor type 12 negatively regulates cardiac HERG channel currents].
Nan Fang Yi Ke Da Xue Xue Bao, 2013 Dec , 33 (1718-22).

487

341910

489

339438

490

339774

Hayashi M et al. Molecular basis of potassium channels in pancreatic duct epithelial cells.
Channels (Austin), 2013 Aug 20 , 7 ().

493

347415

Sun H et al. Are hERG channel blockers also phospholipidosis inducers?
Bioorg. Med. Chem. Lett., 2013 Aug 15 , 23 (4587-90).

495

339911

Kruse M et al. The phosphoinositide sensitivity of the KV channel family.
Channels (Austin), 2013 Aug 1 , 7 ().

496

342466

499

348180

501

343573

502

336028

504

335640

Crotti L et al. Long QT syndrome-associated mutations in intrauterine fetal death.
JAMA, 2013 Apr 10 , 309 (1473-82).

505

340475

507

340476

Islas LD The electric heart of hERG.
J. Gen. Physiol., 2013 Apr , 141 (409-11).

509

343665

He FZ et al. Current pharmacogenomic studies on hERG potassium channels.
Trends Mol Med, 2013 Apr , 19 (227-38).

510

340345

Adaixo R et al. Structural properties of PAS domains from the KCNH potassium channels.
PLoS ONE, 2013 , 8 (e59265).

512

339847

Moric-Janiszewska E et al. Quantitative PCR as an Alternative in the Diagnosis of Long-QT Syndrome.
Biomed Res Int, 2013 , 2013 (418604).

513

339749

Ouadid-Ahidouch H et al. K(+) channels and cell cycle progression in tumor cells.
Front Physiol, 2013 , 4 (220).

514

341891

516

342044

Springer C et al. A fingerprint pair analysis of hERG inhibition data.
Chem Cent J, 2013 , 7 (167).

518

336949

519

334965

522

354138

526

353447

Karnik R et al. Endocytosis of HERG is clathrin-independent and involves arf6.
PLoS ONE, 2013 , 8 (e85630).

527

355052

531

347900

Thai KM et al. Pharmacophore modeling for antitargets.
Curr Top Med Chem, 2013 , 13 (1002-14).

532

347110

534

347723

Pakladok T et al. PIKfyve sensitivity of hERG channels.
Cell. Physiol. Biochem., 2013 , 31 (785-94).

537

334272

542

331258

546

329516

548

331167

Zumhagen S et al. Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.
Herzschrittmacherther Elektrophysiol, 2012 Sep , 23 (211-9).

551

331990

Kapoor A et al. Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.
Antimicrob. Agents Chemother., 2012 Sep , 56 (4891-9).

552

332152

553

332946

Bhattarai D et al. Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
Chem Biol Drug Des, 2012 Sep , 80 (388-97).

554

337807

Lee SH et al. Blockade of human HERG K⁺ channels by rosiglitazone, an antidiabetic drug.
Arch. Pharm. Res., 2012 Sep , 35 (1655-64).

555

341160

558

331438

Abderemane-Ali F et al. Dual effect of phosphatidyl (4,5)-bisphosphate PIP2 on Shaker K+ channels.
J. Biol. Chem., 2012 Oct 19 , 287 (36158-67).

559

338113

Procopiou PA et al. Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.
Bioorg. Med. Chem., 2012 Oct 15 , 20 (6097-108).

562

334483

Högberg T et al. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
Bioorg. Med. Chem. Lett., 2012 Oct 1 , 22 (6039-47).

565

330769

Lee HA et al. Wide spectrum of inhibitory effects of sertraline on cardiac ion channels.
Korean J. Physiol. Pharmacol., 2012 Oct , 16 (327-32).

566

338492

567

334587

569

361144

572

330603

Dong Q et al. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate.
Biol. Pharm. Bull., 2012 Nov 30 , ().

573

337605

Sherhod R et al. Automating knowledge discovery for toxicity prediction using jumping emerging pattern mining.
J Chem Inf Model, 2012 Nov 26 , 52 (3074-87).

574

330683

Portonovo SA et al. hERG drug response measured in droplet bilayers.
Biomed Microdevices, 2012 Nov 18 , ().

576

337920

Bahl A et al. The discovery of CCR3/H1 dual antagonists with reduced hERG risk.
Bioorg. Med. Chem. Lett., 2012 Nov 1 , 22 (6688-93).

577

339349

Edelmann J et al. Long QT syndrome mutation detection by SNaPshot technique.
Int. J. Legal Med., 2012 Nov , 126 (969-73).

578

338757

580

338526

Kam YL et al. HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats.
Pharmacol. Biochem. Behav., 2012 Nov , 103 (33-42).

587

348430

Tang H et al. Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.
ACS Med Chem Lett, 2012 May 10 , 3 (367-72).

589

329946

Jiménez-Vargas JM et al. Interacting sites of scorpion toxin ErgTx1 with hERG1 K+ channels.
Toxicon, 2012 May , 59 (633-41).

590

328952

Boström J et al. Oxadiazoles in medicinal chemistry.
J. Med. Chem., 2012 Mar 8 , 55 (1817-30).

595

328672

Hanrahan P et al. Substituted azaquinazolinones as modulators of GHSr-1a for the treatment of type II diabetes and obesity.
Bioorg. Med. Chem. Lett., 2012 Mar 15 , 22 (2271-8).

597

328744

Bregman H et al. The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR.
Bioorg. Med. Chem. Lett., 2012 Mar 1 , 22 (2033-42).

598

328720

599

328702

Lacombe P et al. 3,4-Diarylpiperidines as potent renin inhibitors.
Bioorg. Med. Chem. Lett., 2012 Mar 1 , 22 (1953-7).

600

328859

602

334103

Kaddar N et al. Tizanidine (Zanaflex): a muscle relaxant that may prolong the QT interval by blocking IKr.
J. Cardiovasc. Pharmacol. Ther., 2012 Mar , 17 (102-9).

604

332944

Peterson LB et al. The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking.
Mol. Pharm., 2012 Jun 4 , 9 (1841-6).

605

328066

607

332373

Pérez-Victoria I et al. Isolation and structural elucidation of cyclic tetrapeptides from Onychocola sclerotica.
J. Nat. Prod., 2012 Jun 22 , 75 (1210-4).

610

332815

Pajouhesh H et al. Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.
Bioorg. Med. Chem. Lett., 2012 Jun 15 , 22 (4153-8).

611

332993

612

333997

Zhao J et al. Inhibitory effects of a bisbenzylisoquinline alkaloid dauricine on HERG potassium channels.
J Ethnopharmacol, 2012 Jun 1 , 141 (685-91).

613

329655

Guo J et al. A422T mutation in HERG potassium channel retained in ER is rescurable by pharmacologic or molecular chaperones.
Biochem. Biophys. Res. Commun., 2012 Jun 1 , 422 (305-10).

614

329725

Van Slyke AC et al. Proton block of the pore underlies the inhibition of hERG cardiac K+ channels during acidosis.
Am. J. Physiol., Cell Physiol., 2012 Jun , 302 (C1797-806).

620

328011

Gönczi M et al. Age-dependent changes in ion channel mRNA expression in canine cardiac tissues.
Gen. Physiol. Biophys., 2012 Jun , 31 (153-62).

622

338936

De Conti L et al. Complexities of 5'splice site definition: implications in clinical analyses.
RNA Biol, 2012 Jun , 9 (911-23).

623

332116

Kulzer M et al. Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230A.
Biochem. Biophys. Res. Commun., 2012 Jul 27 , 424 (315-20).

624

328077

625

332937

Hayashi M et al. An intermediate-conductance Ca2+-activated K+ channel is important for secretion in pancreatic duct cells.
Am. J. Physiol., Cell Physiol., 2012 Jul 15 , 303 (C151-9).

630

331212

Vandenberg JI et al. hERG K(+) channels: structure, function, and clinical significance.
Physiol. Rev., 2012 Jul , 92 (1393-478).

635

327633

Sroubek J et al. The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel.
J. Immunol. Methods, 2012 Jan 31 , 375 (215-22).

637

325256

Hu CW et al. Curcumin inhibits hERG potassium channels in vitro.
Toxicol. Lett., 2012 Jan 25 , 208 (192-6).

639

330078

McCauley JP et al. Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications.
Bioorg. Med. Chem. Lett., 2012 Jan 15 , 22 (1169-73).

640

323814

Nguyen HN et al. Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonists.
Bioorg. Med. Chem. Lett., 2012 Jan 15 , 22 (1055-60).

642

330103

Sundar BG et al. Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.
Bioorg. Med. Chem. Lett., 2012 Jan 1 , 22 (120-3).

644

327739

Krishnan Y et al. Partially dominant mutant channel defect corresponding with intermediate LQT2 phenotype.
Pacing Clin Electrophysiol, 2012 Jan , 35 (3-16).

646

329225

Huang X et al. Comparative effects of Guanfu base A and Guanfu base G on HERG K+ channel.
J. Cardiovasc. Pharmacol., 2012 Jan , 59 (77-83).

647

327094

El Harchi A et al. Molecular determinants of hERG potassium channel inhibition by disopyramide.
J. Mol. Cell. Cardiol., 2012 Jan , 52 (185-95).

650

326470

Yamakawa Y et al. Pharmacophore modeling for hERG channel facilitation.
Biochem. Biophys. Res. Commun., 2012 Feb 3 , 418 (161-6).

658

327074

Dennis AT et al. Molecular determinants of pentamidine-induced hERG trafficking inhibition.
Mol. Pharmacol., 2012 Feb , 81 (198-209).

660

337614

Baaklini I et al. The DNAJA2 substrate release mechanism is essential for chaperone-mediated folding.
J. Biol. Chem., 2012 Dec 7 , 287 (41939-54).

661

337558

663

337150

González Cabrera D et al. Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.
J. Med. Chem., 2012 Dec 27 , 55 (11022-30).

664

330447

Schweikart K et al. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.
Toxicol In Vitro, 2012 Dec 20 , 27 (745-751).

665

330668

Ishii K et al. Endocytic regulation of voltage-dependent potassium channels in the heart.
J. Pharmacol. Sci., 2012 Dec 18 , 120 (264-9).

666

330485

Organ-Darling LE et al. Interactions between hERG and KCNQ1 α-subunits are mediated by their C-termini and modulated by cAMP.
Am. J. Physiol. Heart Circ. Physiol., 2012 Dec 15 , ().

668

337435

Tanis VM et al. Azabenzthiazole inhibitors of leukotriene A₄ hydrolase.
Bioorg. Med. Chem. Lett., 2012 Dec 15 , 22 (7504-11).

670

334347

Warner B Genetic variation in KCNH2 and a unique hERG isoform in patients with schizophrenia: efficacy-safety link.
Am J Psychiatry, 2012 Dec 1 , 169 (1318; author reply 1318-9).

671

330728

673

337869

674

338988

Peters MF et al. Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications.
Assay Drug Dev Technol, 2012 Dec , 10 (525-32).

676

331975

Butini S et al. Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.
J. Med. Chem., 2012 Aug 9 , 55 (6898-915).

678

332788

Liu Y et al. Effects of the natural flavone trimethylapigenin on cardiac potassium currents.
Biochem. Pharmacol., 2012 Aug 15 , 84 (498-506).

679

329517

Twiner MJ et al. Marine Algal Toxin Azaspiracid Is an Open-State Blocker of hERG Potassium Channels.
Chem. Res. Toxicol., 2012 Aug 10 , ().

682

333682

683

329529

Kruse M et al. Regulation of voltage-gated potassium channels by PI(4,5)P2.
J. Gen. Physiol., 2012 Aug , 140 (189-205).

685

348432

Gustina AS et al. HERG potassium channel regulation by the N-terminal eag domain.
Cell. Signal., 2012 Aug , 24 (1592-8).

686

334695

687

338944

Krishnan Y et al. Mechanisms underlying the protein-kinase mediated regulation of the HERG potassium channel synthesis.
Biochim. Biophys. Acta, 2012 Aug , 1823 (1273-84).

688

326400

Jiménez-Vargas JM et al. Toxin modulators and blockers of hERG K(+) channels.
, 2012 Apr 5 , ().

690

328415

Cavalli A et al. Computational design and discovery of "minimally structured" hERG blockers.
J. Med. Chem., 2012 Apr 26 , 55 (4010-4).

693

326668

697

328566

699

326917

Ababneh D et al. Antidepressants Cause Bradycardia and Heart Block in GD 13 Rat Embryos In Vitro.
Birth Defects Res. B Dev. Reprod. Toxicol., 2012 Apr , 95 (184-93).

700

329206

702

333435

703

330155

705

330742

Ceccarini L et al. Ion conduction through the hERG potassium channel.
PLoS ONE, 2012 , 7 (e49017).

706

331096

707

331255

708

331260

Moreno C et al. Polyunsaturated Fatty acids modify the gating of kv channels.
Front Pharmacol, 2012 , 3 (163).

715

327265

Cheng YM et al. Voltage-dependent gating of HERG potassium channels.
Front Pharmacol, 2012 , 3 (83).

719

338568

Ferro F et al. Long-chain acylcarnitines regulate the hERG channel.
PLoS ONE, 2012 , 7 (e41686).

720

338575

Köpfer DA et al. A molecular switch driving inactivation in the cardiac K+ channel HERG.
PLoS ONE, 2012 , 7 (e41023).

721

336998

722

337063

Lazarczyk MJ et al. Selective acquired long QT syndrome (saLQTS) upon risperidone treatment.
BMC Psychiatry, 2012 , 12 (220).

724

338407

Munoz C et al. Stimulation of HERG channel activity by β-catenin.
PLoS ONE, 2012 , 7 (e43353).

725

336819

726

334554

727

339103

Moric-Janiszewska E et al. Molecular diagnostics of families with long-QT syndrome.
Cardiol J, 2012 , 19 (159-67).

731

368031

Zhang GH et al. Cytocompatible performance of thermosensitive poly(N-isopropylacrylamide) nanoparticles.
J Biomater Sci Polym Ed, 2012 , 23 (1569-78).

732

329251

Qu Y et al. hERG potency estimates based upon dose solution analysis: What have we learned?
J Pharmacol Toxicol Methods, 2011 Nov-Dec , 64 (251-7).

733

320233

Champeroux P et al. A step towards characterisation of electrophysiological profile of torsadogenic drugs.
J Pharmacol Toxicol Methods, 2011 May-Jun , 63 (269-78).

734

320161

735

318054

736

323147

Dennis AT et al. Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG.
J. Biol. Chem., 2011 Sep 30 , 286 (34413-25).

737

323252

739

325921

Abi-Gerges N et al. hERG subunit composition determines differential drug sensitivity.
Br. J. Pharmacol., 2011 Sep , 164 (419-32).

745

324739

752

325069

Jeon SH et al. Effects of nortriptyline on QT prolongation: a safety pharmacology study.
Hum Exp Toxicol, 2011 Oct , 30 (1649-56).

754

324877

757

322996

Tester DJ et al. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
Mayo Clin. Proc., 2011 Oct , 86 (941-7).

758

320404

Wang RR et al. The effects of paeoniflorin monomer of a Chinese herb on cardiac ion channels.
Chin. Med. J., 2011 Oct , 124 (3105-11).

762

326262

765

320431

766

320720

768

323882

Furutani K et al. A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents.
Biochem. Biophys. Res. Commun., 2011 Nov 11 , 415 (141-6).

769

324707

González Cabrera D et al. Novel orally active antimalarial thiazoles.
J. Med. Chem., 2011 Nov 10 , 54 (7713-9).

772

324891

Bai YL et al. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
J. Mol. Cell. Cardiol., 2011 Nov , 51 (876-80).

776

319780

Wiles JA et al. Selenophene-containing inhibitors of type IIA bacterial topoisomerases.
J. Med. Chem., 2011 May 12 , 54 (3418-25).

778

319394

Xia M et al. Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.
Toxicol. Appl. Pharmacol., 2011 May 1 , 252 (250-8).

780

322002

Ando F et al. Synergic effects of β-estradiol and erythromycin on hERG currents.
J. Membr. Biol., 2011 May , 241 (31-8).

781

322499

Soma K et al. Abundant expression of KCNE1 in the left ventricle of the miniature pig.
Heart Vessels, 2011 May , 26 (353-6).

782

319357

Schramm A et al. HERG channel inhibitors in extracts of Coptidis rhizoma.
Planta Med., 2011 May , 77 (692-7).

784

318324

786

318185

Luker T et al. Zwitterionic CRTh2 antagonists.
J. Med. Chem., 2011 Mar 24 , 54 (1779-88).

789

318525

790

317371

Gustina AS et al. hERG potassium channel gating is mediated by N- and C-terminal region interactions.
J. Gen. Physiol., 2011 Mar , 137 (315-25).

791

318536

Sun Y et al. A novel mutation in the KCNH2 gene associated with short QT syndrome.
J. Mol. Cell. Cardiol., 2011 Mar , 50 (433-41).

794

319556

796

321949

798

320037

805

323496

Liu Y et al. The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.
Bioorg. Med. Chem. Lett., 2011 Jun 15 , 21 (3712-4).

806

321867

807

355341

808

321510

Zhou PZ et al. Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules.
Acta Pharmacol. Sin., 2011 Jun , 32 (781-8).

809

322176

Vigneault P et al. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
J. Cardiovasc. Pharmacol., 2011 Jun , 57 (690-5).

810

319420

Choi KH et al. hERG channel blockade by externally applied quaternary ammonium derivatives.
Biochim. Biophys. Acta, 2011 Jun , 1808 (1560-6).

812

321969

Johansson A Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists.
Expert Opin Ther Pat, 2011 Jun , 21 (905-25).

815

319213

Tang G et al. Identification of a Novel Bacterial K(+) Channel.
, 2011 Jul 9 , ().

820

321378

Boukharta L et al. Computer simulations of structure-activity relationships for HERG channel blockers.
Biochemistry, 2011 Jul 12 , 50 (6146-56).

823

323604

Couderc JP et al. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.
Heart Rhythm, 2011 Jul , 8 (1036-43).

826

314307

827

316240

829

314092

831

314113

832

316058

834

316350

Han S et al. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
Eur. J. Pharmacol., 2011 Jan 10 , 650 (138-44).

838

314554

839

318709

840

314348

Stump MR et al. Multiple splicing defects caused by hERG splice site mutation 2592+1G>A associated with long QT syndrome.
Am. J. Physiol. Heart Circ. Physiol., 2011 Jan , 300 (H312-8).

848

316577

Du CY et al. Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform.
Biochem. Biophys. Res. Commun., 2011 Feb 11 , 405 (222-7).

851

315586

Hu C et al. Down-regulation of the human ether-a-go-go-related gene in rat cardiac hypertrophy.
Am. J. Med. Sci., 2011 Feb , 341 (119-25).

852

317474

Staudacher I et al. hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.
Naunyn Schmiedebergs Arch. Pharmacol., 2011 Feb , 383 (119-39).

854

319597

Zhu S et al. Molecular diversity and functional evolution of scorpion potassium channel toxins.
Mol. Cell Proteomics, 2011 Feb , 10 (M110.002832).

855

325518

Bentzen BH et al. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
J. Cardiovasc. Pharmacol., 2011 Feb , 57 (223-30).

856

323830

860

325776

Brocklehurst KJ et al. Discovery, optimisation and in vivo evaluation of novel GPR119 agonists.
Bioorg. Med. Chem. Lett., 2011 Dec 15 , 21 (7310-6).

864

327117

Chen J et al. A dual mechanism for I(Ks) current reduction by the pathogenic mutation KCNQ1-S277L.
Pacing Clin Electrophysiol, 2011 Dec , 34 (1652-64).

866

327003

868

327156

Sung RK et al. QTc prolongation and family history of sudden death in a patient with desmin cardiomyopathy.
Pacing Clin Electrophysiol, 2011 Dec , 34 (e105-8).

870

339269

Shao C et al. Electrophysiological study of V535M hERG mutation of LQT2.
J. Huazhong Univ. Sci. Technol. Med. Sci., 2011 Dec , 31 (741-8).

871

323218

Bett GC et al. Models of HERG gating.
Biophys. J., 2011 Aug 3 , 101 (631-42).

872

323216

Es-Salah-Lamoureux Z et al. Blockade of permeation by potassium but normal gating of the G628S nonconducting hERG channel mutant.
Biophys. J., 2011 Aug 3 , 101 (662-70).

873

320986

Giustetto C et al. Long-term follow-up of patients with short QT syndrome.
J. Am. Coll. Cardiol., 2011 Aug 2 , 58 (587-95).

874

323300

Park SJ et al. Bioactive sulfoximines: syntheses and properties of Vioxx analogs.
Bioorg. Med. Chem. Lett., 2011 Aug 15 , 21 (4888-90).

876

323489

879

322591

Witchel HJ Drug-induced hERG block and long QT syndrome.
Cardiovasc Ther, 2011 Aug , 29 (251-9).

880

323720

Du D et al. Multi-scale modeling of glycosylation modulation dynamics in cardiac electrical signaling.
Conf Proc IEEE Eng Med Biol Soc, 2011 Aug , 2011 (104-7).

886

319354

Fox BM et al. Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition.
Bioorg. Med. Chem. Lett., 2011 Apr 15 , 21 (2460-7).

889

319547

El Gebeily G et al. Upregulation of ventricular potassium channels by chronic tamoxifen treatment.
Cardiovasc. Res., 2011 Apr 1 , 90 (68-76).

890

319527

Windisch A et al. Trapping and dissociation of propafenone derivatives in HERG channels.
Br. J. Pharmacol., 2011 Apr , 162 (1542-52).

891

321958

892

321957

Grilo LS et al. Patient with syncope and LQTS carrying a mutation in the PAS domain of the hERG1 channel.
Ann Noninvasive Electrocardiol, 2011 Apr , 16 (213-8).

895

314104

Lahtinen AM et al. KCNE1 D85N polymorphism - a sex-specific modifier in type 1 long QT syndrome?
BMC Med. Genet., 2011 , 12 (11).

896

317963

897

314409

Chen XL et al. Manual whole-cell patch-clamping of the HERG cardiac K+ channel.
Methods Mol. Biol., 2011 , 691 (151-63).

902

319983

Jehle J et al. Novel roles for hERG K(+) channels in cell proliferation and apoptosis.
Cell Death Dis, 2011 , 2 (e193).

904

322783

905

320405

Frolov RV et al. Inhibition of HERG potassium channels by celecoxib and its mechanism.
PLoS ONE, 2011 , 6 (e26344).

911

326212

Yun J et al. Hirsutenone directly blocks human ether-a-go-go related gene K+ channels.
Biol. Pharm. Bull., 2011 , 34 (1815-22).

918

137672

919

141934

Himmel HM et al. QTc shortening with a new investigational cancer drug: a brief case study.
J Pharmacol Toxicol Methods, 2010 Jul-Aug , 62 (72-81).

920

322669

Wilders R et al. Role of the R1135H KCNH2 mutation in Brugada syndrome.
Int. J. Cardiol., 2010 Sep 24 , 144 (149-51).

921

322671

Yasuda S et al. A family of hereditary long QT syndrome caused by Q738X HERG mutation.
Int. J. Cardiol., 2010 Sep 24 , 144 (69-72).

924

318763

Perry M et al. Revealing the structural basis of action of hERG potassium channel activators and blockers.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3157-67).

925

314963

Bokil NJ et al. Molecular genetics of long QT syndrome.
Mol. Genet. Metab., 2010 Sep , 101 (1-8).

926

139260

Mathie A Ion channels as novel therapeutic targets in the treatment of pain.
J. Pharm. Pharmacol., 2010 Sep , 62 (1089-95).

927

142161

Zünkler BJ et al. Comparison of the effects of methadone and heroin on human ether-à-go-go-related gene channels.
Cardiovasc. Toxicol., 2010 Sep , 10 (161-5).

928

140339

Lazzerini PE et al. Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses.
Scand. J. Immunol., 2010 Sep , 72 (213-22).

933

141615

935

315652

Liu Y et al. 9-Dihydroerythromycins as non-antibiotic motilin receptor agonists.
Bioorg. Med. Chem. Lett., 2010 Oct 1 , 20 (5658-61).

938

314976

Larsen AP Role of ERG1 isoforms in modulation of ERG1 channel trafficking and function.
Pflugers Arch., 2010 Oct , 460 (803-12).

939

314546

Larsen AP et al. Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels.
Br. J. Pharmacol., 2010 Oct , 161 (614-28).

940

314755

Jeong I et al. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
Pflugers Arch., 2010 Oct , 460 (851-62).

941

314716

Hondeghem LM et al. Oscillations of cardiac wave length and proarrhythmia.
Naunyn Schmiedebergs Arch. Pharmacol., 2010 Oct , 382 (367-76).

942

316114

Du CY et al. Acidosis impairs the protective role of hERG K(+) channels against premature stimulation.
J. Cardiovasc. Electrophysiol., 2010 Oct , 21 (1160-9).

944

140425

Abela D et al. The effect of drugs with ion channel-blocking activity on the early embryonic rat heart.
Birth Defects Res. B Dev. Reprod. Toxicol., 2010 Oct , 89 (429-40).

947

138329

Sordel T et al. The development of high quality seals for silicon patch-clamp chips.
Biomaterials, 2010 Oct , 31 (7398-410).

950

314367

Van Slyke AC et al. Mutations within the S4-S5 linker alter voltage sensor constraints in hERG K+ channels.
Biophys. J., 2010 Nov 3 , 99 (2841-52).

953

316492

Pryde DC et al. An in situ oxidation strategy towards overcoming hERG affinity.
Bioorg. Med. Chem. Lett., 2010 Nov 15 , 20 (6400-4).

954

314649

Anderson JT et al. Investigation of 4-piperidinols as novel H3 antagonists.
Bioorg. Med. Chem. Lett., 2010 Nov 1 , 20 (6246-9).

955

314633

Rankovic Z et al. Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG.
Bioorg. Med. Chem. Lett., 2010 Nov 1 , 20 (6237-41).

958

316112

Sy RW et al. Repolarization dynamics during exercise discriminate between LQT1 and LQT2 genotypes.
J. Cardiovasc. Electrophysiol., 2010 Nov , 21 (1242-6).

965

137011

967

138616

Gu SJ et al. Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers.
Bioorg. Med. Chem. Lett., 2010 May 1 , 20 (2705-8).

968

139337

Allegue C et al. A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system.
Electrophoresis, 2010 May , 31 (1648-55).

969

139824

Kim KS et al. Blockade of hERG K(+) channel by antimalarial drug, primaquine.
Arch. Pharm. Res., 2010 May , 33 (769-73).

970

138721

971

322826

Möller C Keeping the rhythm: hERG and beyond in cardiovascular safety pharmacology.
Expert Rev Clin Pharmacol, 2010 May , 3 (321-9).

972

124980

975

137828

Xing J et al. Block effect of capsaicin on hERG potassium currents is enhanced by S6 mutation at Y652.
Eur. J. Pharmacol., 2010 Mar 25 , 630 (1-9).

976

137735

Stary A et al. Toward a consensus model of the HERG potassium channel.
ChemMedChem, 2010 Mar 1 , 5 (455-67).

977

136555